10X Genomics (TXG) - Stock Price & Dividends

10X Genomics, Inc., listed on NASDAQ as TXG, is a leading life science technology company. The company focuses on creating and distributing cutting-edge instruments, consumables, and software designed for analyzing biological systems worldwide. Operating in regions such as North America, Europe, the Middle East, Africa, China, and the Asia Pacific, 10X Genomics offers a wide range of innovative solutions for researchers and scientists.

10X Genomics delivers advanced products like chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables essential for biological analysis. One of its flagship offerings is the single-cell solutions that are compatible with chromium instruments. These solutions include single-cell gene expression analysis, single-cell immune profiling, single-cell Assay for Transposase Accessible Chromatin (ATAC), and single-cell multiome ATAC + gene expression technology, enabling precise measurement of gene activity and epigenetic programming in thousands of cells in a single experiment.

Moreover, 10X Genomics also provides the visium spatial gene expression solution, allowing researchers to assess spatial gene expression patterns within tissue samples. When combined with immunofluorescence, this solution enables gene expression and protein co-detection, paving the way for comprehensive biological analyses.

Catering to a diverse clientele that includes academic, government, biopharmaceutical, biotechnology, and other institutions, 10X Genomics has established itself as a trusted partner in the scientific community. Originally known as 10X Technologies, Inc., the company rebranded as 10X Genomics, Inc. in November 2014. Founded in 2012, the company's headquarters are located in Pleasanton, California. For more information, visit their official website at https://www.10xgenomics.com.